{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:24:09Z","timestamp":1791620649786,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03100-4","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T22:28:12Z","timestamp":1737239292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Neutrophil elastase inhibitor (Sivelestat) in the treatment of acute respiratory distress syndrome induced by COVID-19: a multicenter retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunzi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenge","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,19]]},"reference":[{"issue":"10229","key":"3100_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"10","key":"3100_CR2","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00134-020-06211-2","volume":"46","author":"J Xie","year":"2020","unstructured":"Xie J, Wu W, Li S, Hu Y, Hu M, Li J, Yang Y, Huang T, Zheng K, Wang Y, et al. Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study. Intensive Care Med. 2020;46(10):1863\u201372.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3100_CR3","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12967-022-03767-z","volume":"20","author":"R Karki","year":"2022","unstructured":"Karki R, Kanneganti TD. Innate immunity, cytokine storm, and inflammatory cell death in COVID-19. J Transl Med. 2022;20(1):542.","journal-title":"J Transl Med"},{"issue":"6","key":"3100_CR4","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/jcpt.13251","volume":"45","author":"A Sahebnasagh","year":"2020","unstructured":"Sahebnasagh A, Saghafi F, Safdari M, Khataminia M, Sadremomtaz A, Talaei Z, Rezai Ghaleno H, Bagheri M, Habtemariam S, Avan R. Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury\/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19. J Clin Pharm Ther. 2020;45(6):1515\u20139.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"3100_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250010","volume":"53","author":"MC Cesta","year":"2023","unstructured":"Cesta MC, Zippoli M, Marsiglia C, Gavioli EM, Cremonesi G, Khan A, Mantelli F, Allegretti M, Balk R. Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and immunothrombosis. Eur J Immunol. 2023;53(1): e2250010.","journal-title":"Eur J Immunol"},{"issue":"4","key":"3100_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1440-1843.2008.01283.x","volume":"13","author":"S Hashimoto","year":"2008","unstructured":"Hashimoto S, Okayama Y, Shime N, Kimura A, Funakoshi Y, Kawabata K, Ishizaka A, Amaya F. Neutrophil elastase activity in acute lung injury and respiratory distress syndrome. Respirology. 2008;13(4):581\u20134.","journal-title":"Respirology"},{"issue":"10","key":"3100_CR7","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.21037\/tp-22-441","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang M, Zhang H, Wang Y, Du Y, Guo Z, Ma L, Zhou Y, Zhang H, Liu L. Sivelestat improves clinical outcomes and decreases ventilator-associated lung injury in children with acute respiratory distress syndrome: a retrospective cohort study. Transl Pediatr. 2022;11(10):1671\u201381.","journal-title":"Transl Pediatr"},{"key":"3100_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108516","volume":"104","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE. Neutrophil extracellular traps (NETs) and Covid-19: a new frontiers for therapeutic modality. Int Immunopharmacol. 2022;104: 108516.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3100_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s13054-020-03023-0","volume":"24","author":"MMA Mohamed","year":"2020","unstructured":"Mohamed MMA, El-Shimy IA, Hadi MA. Neutrophil Elastase Inhibitors: a potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications? Crit Care. 2020;24(1):311.","journal-title":"Crit Care"},{"issue":"2","key":"3100_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0006-291X(91)91862-7","volume":"177","author":"K Kawabata","year":"1991","unstructured":"Kawabata K, Suzuki M, Sugitani M, Imaki K, Toda M, Miyamoto T. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun. 1991;177(2):814\u201320.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3100_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1165\/rcmb.2016-0158OC","volume":"56","author":"KI Tanaka","year":"2017","unstructured":"Tanaka KI, Tamura F, Sugizaki T, Kawahara M, Kuba K, Imai Y, Mizushima T. Evaluation of lecithinized superoxide dismutase for the prevention of acute respiratory distress syndrome in animal models. Am J Respir Cell Mol Biol. 2017;56(2):179\u201390.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3100_CR12","doi-asserted-by":"crossref","unstructured":"Sercundes MK, Ortolan LS, Debone D, Soeiro-Pereira PV, Gomes E, Aitken EH, Condino-Neto A, Russo M, D' Imp\u00e9rio Lima MR, Alvarez JM, et al. Targeting neutrophils to prevent malaria-associated acute lung injury\/acute respiratory distress syndrome in mice. PLoS Pathog. 2016; 12(12):e1006054.","DOI":"10.1371\/journal.ppat.1006054"},{"issue":"9","key":"3100_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/13543784.2023.2263366","volume":"32","author":"MG Matera","year":"2023","unstructured":"Matera MG, Rogliani P, Ora J, Calzetta L, Cazzola M. A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome. Expert Opin Investig Drugs. 2023;32(9):793\u2013802.","journal-title":"Expert Opin Investig Drugs"},{"issue":"11","key":"3100_CR14","doi-asserted-by":"publisher","first-page":"11910","DOI":"10.21037\/apm-21-3164","volume":"10","author":"X Gao","year":"2021","unstructured":"Gao X, Zhang R, Lei Z, Guo X, Yang Y, Tian J, Huang L. Efficacy, safety and pharmacoeconomics of sivelestat sodium in the treatment of septic acute respiratory distress syndrome: a retrospective cohort study. Ann Palliat Med. 2021;10(11):11910\u20137.","journal-title":"Ann Palliat Med"},{"issue":"8","key":"3100_CR15","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1097\/01.CCM.0000133332.48386.85","volume":"32","author":"BG Zeiher","year":"2004","unstructured":"Zeiher BG, Artigas A, Vincent JL, Dmitrienko A, Jackson K, Thompson BT, Bernard G, STRIVE Study Group. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med. 2004;32(8):1695\u2013702.","journal-title":"Crit Care Med"},{"issue":"21","key":"3100_CR16","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2022.7993","volume":"327","author":"W Alhazzani","year":"2022","unstructured":"Alhazzani W, Parhar KKS, Weatherald J, Al Duhailib Z, Alshahrani M, Al-Fares A, Buabbas S, Cherian SV, Munshi L, Fan E, COVI-PRONE Trial Investigators and the Saudi Critical Care Trials Group, et al. Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure: a randomized clinical trial. JAMA. 2022;327(21):2104\u201313.","journal-title":"JAMA"},{"issue":"3","key":"3100_CR17","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1164\/ajrccm\/138.3.720","volume":"138","author":"JF Murray","year":"1988","unstructured":"Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720\u20133.","journal-title":"Am Rev Respir Dis"},{"key":"3100_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/DDDT.S36436","volume":"6","author":"Y Tsuboko","year":"2012","unstructured":"Tsuboko Y, Takeda S, Mii S, Nakazato K, Tanaka K, Uchida E, Sakamoto A. Clinical evaluation of sivelestat for acute lung injury\/acute respiratory distress syndrome following surgery for abdominal sepsis. Drug Des Devel Ther. 2012;6:273\u20138.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"3100_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/SHK.0b013e3181aa95c4","volume":"33","author":"M Hayakawa","year":"2010","unstructured":"Hayakawa M, Katabami K, Wada T, Sugano M, Hoshino H, Sawamura A, Gando S. Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients. Shock. 2010;33(1):14\u20138.","journal-title":"Shock"},{"key":"3100_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/DDDT.S42004","volume":"7","author":"S Miyoshi","year":"2013","unstructured":"Miyoshi S, Hamada H, Ito R, Katayama H, Irifune K, Suwaki T, Nakanishi N, Kanematsu T, Dote K, Aibiki M, et al. Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis. Drug Des Devel Ther. 2013;7:305\u201316.","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"3100_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1164\/rccm.202004-1226LE","volume":"202","author":"AF Haudebourg","year":"2020","unstructured":"Haudebourg AF, Perier F, Tuffet S, de Prost N, Razazi K, Mekontso Dessap A, Carteaux G. Respiratory mechanics of COVID-19- versus non-COVID-19-associated acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;202(2):287\u201390.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"3100_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S2213-2600(20)30370-2","volume":"8","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Tonetti T, Protti A, Langer T, Girardis M, Bellani G, Laffey J, Carrafiello G, Carsana L, Rizzuto C, collaborators, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8(12):1201\u20138.","journal-title":"Lancet Respir Med"},{"key":"3100_CR23","first-page":"621","volume":"10","author":"N Aikawa","year":"2014","unstructured":"Aikawa N, Kawasaki Y. Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome. Ther Clin Risk Manag. 2014;10:621\u20139.","journal-title":"Ther Clin Risk Manag"},{"issue":"10","key":"3100_CR24","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1038\/s41375-021-01374-3","volume":"35","author":"A Neubauer","year":"2021","unstructured":"Neubauer A, Johow J, Mack E, Burchert A, Meyn D, Kadlubiec A, Torje I, Wulf H, Vogelmeier CF, Hoyer J, et al. The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS). Leukemia. 2021;35(10):2917\u201323.","journal-title":"Leukemia"},{"issue":"1","key":"3100_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/13543784.2020.1699531","volume":"29","author":"PL Silva","year":"2020","unstructured":"Silva PL, Pelosi P, Rocco PRM. Personalized pharmacological therapy for ARDS: a light at the end of the tunnel. Expert Opin Investig Drugs. 2020;29(1):49\u201361.","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"3100_CR26","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/ATVBAHA.120.315267","volume":"41","author":"H Ng","year":"2021","unstructured":"Ng H, Havervall S, Rosell A, Aguilera K, Parv K, von Meijenfeldt FA, Lisman T, Mackman N, Th\u00e5lin C, Phillipson M. Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19. Arterioscler Thromb Vasc Biol. 2021;41(2):988\u201394.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"3100_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1590\/1516-3180.2022.0170.r1.01072022","volume":"141","author":"PRL Almeida","year":"2022","unstructured":"Almeida PRL, Person OC, Puga MEDS, Giusti MF, Pinto ACPN, Rocha AP, Atallah \u00c1N. Effectiveness and safety of tocilizumab for COVID-19: a systematic review and meta-analysis of randomized clinical trials. Sao Paulo Med J. 2022;141(2):168\u201376.","journal-title":"Sao Paulo Med J"},{"issue":"1","key":"3100_CR28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s40001-023-01403-0","volume":"28","author":"J Sun","year":"2023","unstructured":"Sun J, Wang S, Ma X, Wei Q, Peng Y, Bai Y, Miao G, Meng C, Liu P. Efficacy and safety of baricitinib for the treatment of hospitalized adults with COVID-19: a systematic review and meta-analysis. Eur J Med Res. 2023;28(1):536.","journal-title":"Eur J Med Res"},{"issue":"4","key":"3100_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/ijciis.ijciis_23_23","volume":"13","author":"R Patnaik","year":"2023","unstructured":"Patnaik R, Chandramouli T, Mishra SB. A systematic review and meta-analysis of randomized controlled trials with trial sequence analysis of remdesivir for COVID-19 treatment. Int J Crit Illn Inj Sci. 2023;13(4):184\u201391.","journal-title":"Int J Crit Illn Inj Sci"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03100-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03100-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03100-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T22:28:15Z","timestamp":1737239295000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03100-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3100"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03100-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3932435\/v1","asserted-by":"object"}]},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,19]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Permission to conduct the study was obtained from the Ethics Committee of the First Hospital of Jilin University (No.22K091-001; December 18, 2022; Clinical study of neutrophil elastase in treating ARDS caused by infection), informed consent was waived and data were anonymously collected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}